Results 21 to 30 of about 13,344 (260)

Onchocerca volvulus and epilepsy: A comprehensive review using the Bradford Hill criteria for causation [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2021
Robert Colebunders   +2 more
exaly   +2 more sources

The onchocerciasis hypothesis of nodding syndrome.

open access: yesPLoS Neglected Tropical Diseases, 2023
Nodding syndrome (NS) is a phenotypic presentation of onchocerciasis-associated epilepsy (OAE). OAE is an important public health problem in areas with high ongoing Onchocerca volvulus transmission.
Robert Colebunders   +2 more
doaj   +1 more source

Galectins from Onchocerca ochengi and O. volvulus and their immune recognition by Wistar rats, Gudali zebu cattle and human hosts

open access: yesBMC Microbiology, 2021
Background During the last two decades research on animal filarial parasites, especially Onchocerca ochengi, infecting cattle in savanna areas of Africa revealed that O.
Ngwafu Nancy Ngwasiri   +9 more
doaj   +1 more source

A rare case of cutaneous onchocerciasis in North-East India, review of literature

open access: yesIndian Dermatology Online Journal, 2020
Onchocerca volvulus is a spirurid nematode that mainly affects the rural poor of Sub-Saharan Africa, Yemen, and parts of Central and South America. River blindness caused by Onchocerca volvulus is considered to be the second most common infectious cause ...
M M Pasha   +3 more
doaj   +1 more source

Emodepside targets SLO-1 channels of Onchocerca ochengi and induces broad anthelmintic effects in a bovine model of onchocerciasis.

open access: yesPLoS Pathogens, 2021
Onchocerciasis (river blindness), caused by the filarial worm Onchocerca volvulus, is a neglected tropical disease mostly affecting sub-Saharan Africa and is responsible for >1.3 million years lived with disability. Current control relies almost entirely
Germanus S Bah   +17 more
doaj   +1 more source

Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia. [PDF]

open access: goldParasit Vectors
Kanza EM   +19 more
europepmc   +3 more sources

Ivermectin inhibits growth of Chlamydia trachomatis in epithelial cells. [PDF]

open access: yesPLoS ONE, 2012
Ivermectin is currently approved for treatment of both clinical and veterinary infections by nematodes, including Onchocerca cervicalis in horses and Onchocerca volvulus in humans.
Matthew A Pettengill   +4 more
doaj   +1 more source

Serotonin Levels in the Serum of Persons with Onchocerciasis-Associated Epilepsy: A Case-Control Study

open access: yesPathogens, 2021
Onchocerciasis-associated epilepsy (OAE) is a devastating childhood disorder occurring in areas with high Onchocerca volvulus transmission. Despite epidemiological evidence showing the association between O.
Melissa Krizia Vieri   +9 more
doaj   +1 more source

A four-antigen mixture for rapid assessment of Onchocerca volvulus infection. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2009
Onchocerciasis, an infection caused by the filarial nematode Onchocerca volvulus, is a major public health concern. Given the debilitating symptoms associated with onchocerciasis and concerns about recrudescence in areas of previous onchocerciasis ...
Peter D Burbelo   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy